Varex Imaging Corporation(VREX)Earnings, Financials & Key RatiosVarex Imaging Corporation (VREX) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q2
the company's inability to maintain consistent profitability, highlighted by a -3.8% net margin in 2026Q2, suggests significant execution risk in a competitive medical device landscape.
Varex Imaging Corporation (VREX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Varex Imaging Corporation (VREX) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.21vs $0.22-4.5% | $216Mvs $217M-0.4% |
| Q1 2026 | Feb 10, 2026 | $0.19vs $0.14+35.7% | $210Mvs $208M+0.9% |
| Q4 2025 | Nov 18, 2025 | $0.37vs $0.18+105.6% | $229Mvs $206M+11.2% |
| Q3 2025 | Aug 7, 2025 | $0.18vs $0.04+350.0% | $203Mvs $219M-7.4% |
Recent stock market news and headlines for Varex Imaging Corporation (VREX)
The consensus price target hints at a 61.6% upside potential for VAREX IMAGING (VREX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Key metrics vs top competitors for Varex Imaging Corporation (VREX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $10.29 | $433.21M | -6.05 | 4.14% | -8.32% | -13.57% | — | |
| $10.78 | $2.16B | -3.59 | -2.98% | -17.06% | -41.19% | — | |
| $0.88 | $61.2M | -0.76 | 15.4% | -576.13% | -47.09% | — | |
| $8.83 | $1.34B | -9.20 | 24.95% | -21.07% | -443.09% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — | |
| $399.69 | $141.96B | 50.79 | 20.51% | 28.15% | 16.89% | — |
Varex Imaging Corporation (VREX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Varex Imaging Corporation (VREX) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
Mar 16, 2026·SEC
Feb 13, 2026·SEC
Get notified when VREX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Varex Imaging Corporation (VREX) stock FAQ — growth, dividends, profitability & financials explained
Varex Imaging Corporation (VREX) reported $857.5M in revenue for fiscal year 2025. This represents a 25% increase from $685.2M in 2014.
Varex Imaging Corporation (VREX) grew revenue by 4.1% over the past year. Growth has been modest.
Varex Imaging Corporation (VREX) reported a net loss of $82.7M for fiscal year 2025.
Varex Imaging Corporation (VREX) has a return on equity (ROE) of -13.6%. Negative ROE indicates the company is unprofitable.
Varex Imaging Corporation (VREX) had negative free cash flow of $30.8M in fiscal year 2025, likely due to heavy capital investments.
